Novel natural killer cell-mediated cancer immunotherapeutic activity of anisomycin against hepatocellular carcinoma cells

Despite advances in the clinical management of hepatocellular carcinoma (HCC), this form of cancer remains the second leading cause of cancer-related death worldwide. Currently, there are few treatment options for advanced HCC. Therefore, novel treatment strategies for HCC are required. Here, we des...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Miok, Lee, Seon-Jin, Shin, Sangsu, Park, Kang-Seo, Park, Sang Yoon, Lee, Chang Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045618/
https://www.ncbi.nlm.nih.gov/pubmed/30006566
http://dx.doi.org/10.1038/s41598-018-29048-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045618/
https://www.ncbi.nlm.nih.gov/pubmed/30006566
http://dx.doi.org/10.1038/s41598-018-29048-8

Ejemplares similares